SKI Market

Indian Indices

Sensex

82,814.71 316.57
( 0.38%)

Global Indices

Nasdaq

49,649.56 233.39
(0.47%)

Dow Jones

6,930.29 47.40
(0.69%)

Hang Seng

56,838.27 -629.56
(-1.10%)

Nikkei 225

10,691.66 64.62
(0.61%)

Forex

USD-INR

91.03 0.34
(0.37%)

EUR-INR

107.23 0.00
(0.00%)

GBP-INR

122.67 -0.16
(-0.13%)

JPY-INR

0.59 0.00
(-0.25%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Jubilant Pharmova Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

530019

INE700A01033

140.8744507

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

JUBLPHARMA

13839.19

EPS(TTM)

Face Value()

Div & Yield %

0.57

Back

Sanjivani Paranteral consolidated net profit declines 28.70% in the September 2025 quarter

Nov 15,2025

Net profit of Sanjivani Paranteral declined 28.70% to Rs 1.64 crore in the quarter ended September 2025 as against Rs 2.30 crore during the previous quarter ended September 2024. Sales declined 14.51% to Rs 15.50 crore in the quarter ended September 2025 as against Rs 18.13 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	15.50	18.13	-15
OPM %	14.52	15.72	-
PBDT	2.36	3.06	-23
PBT	2.19	2.92	-25
NP	1.64	2.30	-29

82,814.71 316.57 ( 0.38%)

49,649.56 233.39 (0.47%)

6,930.29 47.40 (0.69%)

56,838.27 -629.56 (-1.10%)

10,691.66 64.62 (0.61%)

91.03 0.34 (0.37%)

107.23 0.00 (0.00%)

122.67 -0.16 (-0.13%)

0.59 0.00 (-0.25%)